Cefuzonam: Difference between revisions
Jump to navigation
Jump to search
imported>David E. Volk (New page: {{subpages}} {{Chem infobox |align=right |image=center|thumb|250px|{{#ifexist:Template:Cefadroxil.jpg/credit|{{Cefadroxil.jpg/credit}}<br/>|}} |width=250px |molname...) |
mNo edit summary |
||
| Line 21: | Line 21: | ||
== References == | == References == | ||
<references/> | <references/> | ||
{{CZMed}} | {{CZMed}}[[Category:Suggestion Bot Tag]] | ||
Latest revision as of 07:00, 26 July 2024
|
| |||||||
| cefuzonam | |||||||
| |||||||
| Uses: | antibiotic drug | ||||||
| Properties: | beta-lactam | ||||||
| Hazards: | see drug interactions | ||||||
| |||||||
Cefuzonam is a second-generation cephalosporin type of antibiotic medication used to treat bacterial infections. Its antibacterial activity is due to the presence of a beta-lactam core structure, which binds with penicillin-binding proteins within bacterial cells, thereby inhibiting cell wall synthesis in the bacteria.
References
The most up-to-date information about Cefuzonam and other drugs can be found at the following sites.
- Cefuzonam - FDA approved drug information (drug label) from DailyMed (U.S. National Library of Medicine).
- Cefuzonam - Drug information for consumers from MedlinePlus (U.S. National Library of Medicine).
- Cefuzonam - Detailed information from DrugBank.